JP2022514335A5 - - Google Patents

Info

Publication number
JP2022514335A5
JP2022514335A5 JP2021535300A JP2021535300A JP2022514335A5 JP 2022514335 A5 JP2022514335 A5 JP 2022514335A5 JP 2021535300 A JP2021535300 A JP 2021535300A JP 2021535300 A JP2021535300 A JP 2021535300A JP 2022514335 A5 JP2022514335 A5 JP 2022514335A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
formula
conjugate
covalent bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021535300A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022514335A (ja
Filing date
Publication date
Priority claimed from GBGB1820626.8A external-priority patent/GB201820626D0/en
Application filed filed Critical
Publication of JP2022514335A publication Critical patent/JP2022514335A/ja
Publication of JP2022514335A5 publication Critical patent/JP2022514335A5/ja
Priority to JP2025007027A priority Critical patent/JP2025072404A/ja
Pending legal-status Critical Current

Links

JP2021535300A 2018-12-18 2019-12-18 コンジュゲート Pending JP2022514335A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025007027A JP2025072404A (ja) 2018-12-18 2025-01-17 コンジュゲート

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1820626.8 2018-12-18
GBGB1820626.8A GB201820626D0 (en) 2018-12-18 2018-12-18 Conjugates
PCT/EP2019/086120 WO2020127602A1 (en) 2018-12-18 2019-12-18 Conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025007027A Division JP2025072404A (ja) 2018-12-18 2025-01-17 コンジュゲート

Publications (2)

Publication Number Publication Date
JP2022514335A JP2022514335A (ja) 2022-02-10
JP2022514335A5 true JP2022514335A5 (cg-RX-API-DMAC7.html) 2022-12-20

Family

ID=65147114

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021535300A Pending JP2022514335A (ja) 2018-12-18 2019-12-18 コンジュゲート
JP2025007027A Pending JP2025072404A (ja) 2018-12-18 2025-01-17 コンジュゲート

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025007027A Pending JP2025072404A (ja) 2018-12-18 2025-01-17 コンジュゲート

Country Status (11)

Country Link
US (1) US20220054658A1 (cg-RX-API-DMAC7.html)
EP (1) EP3897737A1 (cg-RX-API-DMAC7.html)
JP (2) JP2022514335A (cg-RX-API-DMAC7.html)
KR (1) KR20210106496A (cg-RX-API-DMAC7.html)
CN (1) CN113474007A (cg-RX-API-DMAC7.html)
AU (1) AU2019400788A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021011860A2 (cg-RX-API-DMAC7.html)
CA (1) CA3123960A1 (cg-RX-API-DMAC7.html)
GB (1) GB201820626D0 (cg-RX-API-DMAC7.html)
MX (1) MX2021006802A (cg-RX-API-DMAC7.html)
WO (1) WO2020127602A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114685430B (zh) * 2022-03-18 2023-07-21 浙江大学 芬苯达唑类似物及制备方法和应用
WO2024049306A1 (en) * 2022-08-31 2024-03-07 Lopez Gonzalez Ricardo Chemical conjugates, compositions, and methods of preparation and use thereof
CN120987848B (zh) * 2025-07-10 2026-07-21 广州大学 一种含胍基结构单元的ε-己内酰胺化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068485B1 (en) 1981-07-01 1987-11-11 Sanraku Incorporated Novel antibiotics and process for production thereof
EP2370411A4 (en) * 2008-12-05 2012-10-24 Univ Oregon Health & Science COMPOUNDS WITH ANTIPARASITIC OR ANTI-INFECTIOUS EFFECT
JP5852658B2 (ja) * 2010-09-24 2016-02-03 ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン デユビキチナーゼ阻害剤およびその使用方法
US20130345270A1 (en) * 2010-11-12 2013-12-26 Waake Forest University Health Sciences Methods of treating cancer and other disorders
EP2665738B1 (en) 2011-01-18 2018-09-26 The Royal Institution for the Advancement of Learning/McGill University Aminoglycosides for use in the treatment of bacterial infection
US9108942B1 (en) 2014-11-05 2015-08-18 Mahesh Kandula Compositions and methods for the treatment of moderate to severe pain
ES2907461T3 (es) * 2015-01-20 2022-04-25 Boehringer Ingelheim Animal Health Usa Inc Compuestos antihelmínticos, composiciones y procedimientos de uso de los mismos
WO2019060634A1 (en) 2017-09-20 2019-03-28 Thiogenesis Therapeutics, Inc. METHODS OF TREATING CYSTEAMINE SENSITIVE DISORDERS

Similar Documents

Publication Publication Date Title
JP5932640B2 (ja) インフルエンザを治療するための化合物および方法
TW202140040A (zh) N4-羥基胞苷及衍生物及與其相關之抗病毒用途
TW523410B (en) Non-immunosuppresive 2-pipecolic acid derivative-containing pharmaceutical compositions for promoting neuronal growth and regeneration in a neurophathological condition where neuronal repair can be facilitated, for treating a neurological disorder
TW202385B (cg-RX-API-DMAC7.html)
RU2589697C2 (ru) Способы получения стабильных жидких лекарственных препаратов и их композиции
JP2016526558A (ja) キナーゼ阻害剤としてのプリノン化合物
JP6619420B2 (ja) Metap−2阻害剤としてのピロリジノン誘導体
JP7080346B2 (ja) 老化細胞によって引き起こされるかまたは媒介される状態の臨床管理における使用のためおよびがんを治療するための、Bclファミリーアンタゴニストであるホスホノアミダート
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
US20110124683A1 (en) Use of CRTH2 Antagonist Compounds
JP5693970B2 (ja) ベンゾフェナントリジン構造を有する抗腫瘍薬およびそれらを含有する製剤
TW201619142A (zh) 利用替唑尼特(tizoxanide)、其類似物或鹽類之前驅藥的組成物及治療方法
AR045040A1 (es) Derivados de compuestos espiroazabiciclicos, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos
CN110461862A (zh) 用于治疗由衰老细胞介导的病症和用于治疗癌症的基于肽的蛋白酶体抑制剂
RU2007138264A (ru) N-[3-(1-АМИНО-5,6,7,8-ТЕТРАГИДРО-2,4,4b-ТРИАЗАФЛУОРЕН-9-ИЛ)ФЕНИЛ]БЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИН/ТРЕОНИНКИНАЗ, ПРЕЖДЕ ВСЕГО КИНАЗ В-RAF
JP2025502748A (ja) Flt3の阻害剤としてのピラジン化合物
ES2229736T3 (es) Derivados de bis-indol y su uso como agentes antiinflamatorios.
CA2974611A1 (en) Conjugates of hyaluronan hemiesters with pharmaceutically active substances
KR20080017334A (ko) 항바이러스 화합물
US20070112043A1 (en) Acylated and non-acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides, and uses thereof
KR20070028462A (ko) 메니에르병의 예방 및/또는 치료제
JPH10511931A (ja) 非インシュリン依存性糖尿病の患者において胃空腹を抑制する1,5−ベンゾジアゼピン誘導体の使用
US20110053884A1 (en) Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase
CN103827100B (zh) 用于降低血清尿酸的[1,2,4]噻二嗪1,1-二氧化物化合物
JP5386476B2 (ja) 頭蓋外傷の治療のための4−シクロプロピルメトキシ−n−(3,5−ジクロロ−1−オキシド−4−ピリジン−4−イル)−5−(メトキシ)ピリジン−2−カルボキサミドの使用